Prediction of sensitivity of esophageal tumors to adjuvant chemotherapy by cDNA microarray analysis of gene-expression profiles.
暂无分享,去创建一个
T Tanaka | T. Takagi | Yusuke Nakamura | Toshihiro Tanaka | T. Tsunoda | Y. Furukawa | O. Kitahara | Y. Nakamura | K. Hirata | C. Kihara | H. Yamana | H. Zembutsu | K. Ono | R. Yanagawa | Y Nakamura | Y Furukawa | T Tsunoda | Rempei Yanagawa | O Kitahara | K Ono | C Kihara | H Yamana | T Takagi | R Yanagawa | H Zembutsu | K Hirata | T. Takagi | T. Tanaka | Koichi Hirata | Osamu Kitahara
[1] B. Mirkin,et al. S-adenosylmethionine synthetase is overexpressed in murine neuroblastoma cells resistant to nucleoside analogue inhibitors of S-adenosylhomocysteine hydrolase: a novel mechanism of drug resistance. , 1999, Cancer research.
[2] L. Penland,et al. Use of a cDNA microarray to analyse gene expression patterns in human cancer , 1996, Nature Genetics.
[3] M. Hollstein,et al. Amplification of Epidermal Growth Factor Receptor Gene but Updated Version Citing Articles E-mail Alerts Amplification of Epidermal Growth Factor Receptor Gene but No Evidence of Ras Mutations in Primary Human Esophageal Cancers , 2013 .
[4] T Tanaka,et al. Identification by cDNA microarray of genes involved in ovarian carcinogenesis. , 2000, Cancer research.
[5] M. Kool,et al. A family of drug transporters: the multidrug resistance-associated proteins. , 2000, Journal of the National Cancer Institute.
[6] J. Eberwine,et al. Amplified RNA synthesized from limited quantities of heterogeneous cDNA. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[7] R. Eddy,et al. Two chromosomal locations for human ornithine decarboxylase gene sequences and elevated expression in colorectal neoplasia. , 1990, Cancer research.
[8] Overexpression of metallothionein correlates with chemoresistance to cisplatin and prognosis in esophageal cancer. , 1997, Oncology.
[9] T. Takagi,et al. Alterations of gene expression during colorectal carcinogenesis revealed by cDNA microarrays after laser-capture microdissection of tumor tissues and normal epithelia. , 2001, Cancer research.
[10] J. Forbes,et al. EMS1 gene expression in primary breast cancer: relationship to cyclin D1 and oestrogen receptor expression and patient survival , 1998, Oncogene.
[11] M. Bittner,et al. Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays. , 1998, Cancer research.
[12] T. Sugiyama,et al. Gene amplification of int-2 and erbB in human esophageal cancer: relationship to clinicopathological variables. , 1997, Cancer investigation.
[13] W. Hop,et al. Reduced expression of the cadherin–catenin complex in oesophageal adenocarcinoma correlates with poor prognosis , 1997, The Journal of pathology.
[14] D. Beer,et al. Amplification and over‐expression of the EGFR and erbB‐2 genes in human esophageal adenocarcinomas , 1993, International journal of cancer.
[15] M. Jackson,et al. Gene expression profiles of laser-captured adjacent neuronal subtypes , 1999, Nature Medicine.
[16] J. Nesland,et al. P-glycoprotein expression is a marker for chemotherapy resistance and prognosis in advanced ovarian cancer. , 2000, Anticancer research.
[17] T. Zhukov,et al. Prospective detection of preclinical lung cancer: results from two studies of heterogeneous nuclear ribonucleoprotein A2/B1 overexpression. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.
[18] J. Hainsworth,et al. Phase I/II trial of paclitaxel by 1‐hour infusion, carboplatin, and gemcitabine in the treatment of patients with advanced nonsmall cell lung carcinoma , 1999, Cancer.
[19] Ash A. Alizadeh,et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.
[20] D. Botstein,et al. Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[21] V. Chiarion-Sileni,et al. First-line chemotherapy improves the resection rate and long-term survival of locally advanced (T4, any N, M0) squamous cell carcinoma of the thoracic esophagus: final report on 163 consecutive patients with 5-year follow-up. , 1997, Annals of surgery.
[22] J. Morizet,et al. Main drug- and carcinogen-metabolizing enzyme systems in human non-small cell lung cancer and peritumoral tissues. , 1993, Cancer research.
[23] J. Mesirov,et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.
[24] D. Botstein,et al. A gene expression database for the molecular pharmacology of cancer , 2000, Nature Genetics.
[25] Ronald W. Davis,et al. Quantitative Monitoring of Gene Expression Patterns with a Complementary DNA Microarray , 1995, Science.
[26] M. Bittner,et al. Data management and analysis for gene expression arrays , 1998, Nature Genetics.